The trial enrolled 46 preschool children aged 35 years with a confirmed diagnosis of ASD, although the authors did not report the sex distribution, ASD subtypes, symptom severity, or comorbid conditions of the participants
BioWorld Regulatory Cardiovascular Endocrine/metabolic Obesity Small molecule FDA NDA
The effects of glucagon-like peptide-1 receptor agonists and dipeptydilpeptidase-4 inhibitors on blood pressure and cardiovascular complications in diabetes
For example, the combination of 2-deoxyglucose (glycolytic inhibitor), metformin (glycolytic inhibitor), compound C (an AMPK inhibitor), MLN128 (mTOR1 inhibitor), and other glutamine metabolism inhibitors have shown synergistic antitumor effects in some cancer models (Elgogary et al., 2016
BPC-157 is only part of the larger BPC peptide and doesnt occur by itself
FDA Approved Melanotan I has been reviewed and approved by the FDA for safety and efficacy in its approved indications